Saturday, December 17, 2005


EU scientists seek big investment in nanomedicine (Hep C Chronic Fatigue)


EU scientists seek big investment in nanomedicine
ABCNEWS.com - to carry tumor-killing agents into cells, while

Phase III Trial Shows Zadaxin Ineffective for Treatment of
HIV and Hepatitis.com - Health Medical ViroLogic Incorporated Top Articles This Week Phase III Trial Shows Zadaxin Ineffective for Treatment of

Aethlon Medical (AEMD) Provides Progress Report To Wall Street
BioSpace - This is a small safety study of